Compared with the HCC-NVI group, the positive rate of CD8+ T cells in the HCC-MVI TME was significantly decreased (41.3 vs. 20.8% P = 0.001; Figures 7A,B). This evidence concerns the gene CD8A and hepatocellular carcinoma.